Welcome to the Villeneuve Lab
The Villeneuve Lab is interested in how the brain ages with a specific focus on the factors that modify the association between brain lesions and cognitive performances. Our research is motivated by the fact that more than 25% of older adults are considered cognitively normal despite the presence of beta-amyloid in their brain, a hallmark of Alzheimer’s disease. This fact suggests that other factors interact with beta-amyloid to trigger the expression of cognitive deficits in Alzheimer’s disease. It also suggests that actions can be taken to prevent or postpone the expression of disease-related symptoms. The main focus of The Villeneuve Lab’s research is therefore to examine the factors that protect (or worse) the development of cognitive deficits in age-related neurodegenerative diseases. We use a multi-tier approach that includes molecular PET imaging, MRI imaging, neuropsychological testing, and genetics.
Visit our research page to learn more about our ongoing projects.
|New CIHR grant for the Villeneuve lab
23 January 2019
We are happy to announce that Dr. Villeneuve have received a 5-year grant from the Canadian Institutes of Health Research for the project entitled “Preventing the progression of Alzheimer’s disease pathology by targeting the effects of lifestyle factors and personality traits.“
Principal Investigator: Villeneuve, Sylvia C
|Human Amyloid Imaging conference 2019
16-18 January 2019
Dr. Villeneuve, along with Theresa, Alexa, Pierre, and Melissa attended this year’s Human Amyloid Imaging (HAI) conference in Miami to present some of their recent work. You can check their posters here: [Posters]
|Villeneuve lab welcomes Anne Maass
7 January 2019
Anne is a post-doctoral researcher at DNZE Magdeburg Site, Germany. She will collaborate with the Villeneuve lab to study the relations between memory dysregulation and amyloid and tau proteins using task-fMRI data from Prevent-AD.
|MAIN 2018 and McConnell BIC Retreat
10 December 2018
Congratulationss to Julie Gonneaud for receiving best poster and best abstract prizes from the Montreal AI & Neuroscience (MAIN) conference 2018 and McConnell BIC retreat event for her recent project entitled “The preclinical phase of autosomal dominant Alzheimer’s disease is characterized by accelerated brain aging.” [poster]
|Lab’s Christmas dinner
6 December 2018
A very warm Merry Christmas to all, from the Villeneuve lab team.